Clinical Trials Directory

Trials / Completed

CompletedNCT01021787

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF 40 Sunscreen Cream With Micronized TiO2 and Anthelios SX SPF 40 Cream (With Pigmentary TiO2) Into the Stratum Corneum of Compromised (Induced Sunburn) Human Skin

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Loreal USA · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To determine the penetration of micronized and pigmentary TiO2 in Formulas 283419 2 and 760.001 into the stratum corneum of Compromised (Induced Sunburn) human skin via skin stripping of human subjects.

Conditions

Interventions

TypeNameDescription
DRUGTitanium dioxideTopical cream

Timeline

Start date
2009-12-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-11-30
Last updated
2011-06-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01021787. Inclusion in this directory is not an endorsement.

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream (NCT01021787) · Clinical Trials Directory